MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GRI had $3,201K increase in cash & cash equivalents over the period. -$10,189K in free cash flow.

Cash Flow Overview

Change in Cash
$3,201K
Free Cash flow
-$10,189K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Proceeds from issuance of common...
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Payment of deferred stock issuan...
    • Operating lease liabilities
    • Others

Cash Flow
2025-12-31
Net loss
-11,956
Depreciation expense
4
Stock-based compensation expense
793
Change in fair value of warrant liability
0
Change in operating lease right of use assets
48
Prepaid expenses and other current assets
-251
Accounts payable
663
Accrued expenses
59
Operating lease liabilities
-48
Cash used in operating activities
-10,186
Purchase of property and equipment
3
Cash used in investing activities
-3
Proceeds from issuance of common stock in financing transaction / under atm facility-Through Financing
13,000
Proceeds from issuance of common stock in financing transaction / under atm facility-At The Market Offering
2,560
Proceeds from warrant exercise
0
Payment for fractional shares in connection with reverse stock split
1
Payment of deferred stock issuance costs
2,169
Cash provided by financing activities
13,390
Net increase in cash and cash equivalents
3,201
Cash and cash equivalents at beginning of period
5,028
Cash and cash equivalents at end of period
8,229
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock in...$13,000K Proceeds from issuance ofcommon stock in...$2,560K Cash provided byfinancing activities$13,390K Canceled cashflow$2,170K Net increase in cashand cash...$3,201K Canceled cashflow$10,189K Payment of deferredstock issuance costs$2,169K Payment for fractionalshares in connection...$1K Stock-based compensationexpense$793K Accounts payable$663K Prepaid expenses andother current assets-$251K Accrued expenses$59K Change in operatinglease right of use...$48K Depreciation expense$4K Cash used inoperating activities-$10,186K Cash used ininvesting activities-$3K Canceled cashflow$1,818K Net loss-$11,956K Purchase of property andequipment$3K Operating leaseliabilities-$48K

GRI Bio, Inc. (GRI)

GRI Bio, Inc. (GRI)